Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Events

10 Feb 2026 - 13 Feb 2026
17 Apr 2026 - 21 Apr 2026

Improved Antigen Test Detects Filarial Infection

By LabMedica International staff writers
Posted on 05 Jun 2013
A newly introduced diagnostic test for a worm infection that can lead to severe enlargement and deformities of the legs and genitals is far more sensitive than the currently used test. More...


The immunodiagnostic test detects circulating filarial antigen (CFA) in the blood of patients with elephantiasis. It was compared to another commercial card test both in laboratory-banked samples and in fresh samples from the field.

Infectious diseases specialists at the Washington University School of Medicine (St. Louis, MO, USA) tested a panel of well-characterized serum or plasma samples for both assays in the laboratory. A field study was performed in northwestern Liberia. Blood was collected directly into a small 75-µL blood collection pipette for the Filariasis Test Strip and a 100-µL capillary tube supplied with the BinaxNOW Filariasis card test. Both test strip and card are manufactured by Alere Scarborough Inc. (Scarborough, ME, USA) and are read 10 minutes after application of the blood.

In the laboratory evaluation, the test strip produced stronger, sharper positive test lines than the card, and the test strip was more sensitive than the card test. Both tests detected filarial antigenemia in all 88 samples from subjects with Wuchereria bancrofti microfilaremia. Study participants in the field evaluation ranged in age from six to 89 years, and approximately one-half of the subjects tested were female. The sensitivity of the tests was compared for 503 blood samples that had valid results for both tests. The Filariasis test strip produced 26.5% more positive test results with 124/503 compared with 98/503 for the BinaxNOW card test.

Gary J. Weil, MD, the lead author, said, “The older test has had a major impact, but the new one is even better. Annually, medication to treat and prevent the infection is distributed to more than 500 million people worldwide. The improved sensitivity of the new test will help determine whether the mass treatment program has been effective and also identify regions that need additional attention." The new test strip also has a longer shelf life, estimated at two years without refrigeration, compared with three months for the older version, and it is expected to cost less. The study was published on May 20, 2013, in the American Journal of Tropical Medicine and Hygiene.

Related Links:

Washington University School of Medicine

Alere Scarborough Inc



Gold Member
Hybrid Pipette
SWITCH
POC Helicobacter Pylori Test Kit
Hepy Urease Test
ESR Analyzer
TEST1 2.0
Gel Cards
DG Gel Cards
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.